The expanding demand for specific immunological study and therapeutic design has spurred significant Group A streptococcus (Strep A) antibody improvements in recombinant growth factor production. IL-1A, IL-1B, IL-2, and IL-3, each possessing unique functional roles, are frequently produced using various expression systems, including bacterial hosts